10.02.2017 • NewsElaine BurridgeHyosungpdh

Hyosung to Build PDH/PP Unit in Vietnam

(c) Hyosung
(c) Hyosung

South Korean conglomerate Hyosung has signed a Memorandum of Understanding (MoU) with the Vietnamese government to invest a total of $1.2 billion in a propane dehydrogenation (PDH) and PP complex near Ho Chi Minh City in southern Vietnam.

Located at the Cai Mep Industrial Zone in the district of Tan Thanh district, Ba Ria-Vung Tau province, the complex will comprise a PDH unit, two PP plants, an LPG storage tank and a warehouse for both LPG and petrochemical products.

The project will be built in two stages. In the first phase, Hyosung will spend $133 million to build the LPG tank and $336 million on the first PP plant. In a second phase, investments of $496 million and $226 million will be made in the PDH plant and second PP line, respectively. However, Hyosung told local media the size of the investments and the schedule could change.

The South Korean group has not disclosed capacity details for the PDH and PP facilities, nor revealed a timescale for the overall project, which is aimed at increasing its share for PP in markets with promising potential such as Vietnam, China and others in southeast Asia.

Hyosung also plans to spend around $122 million on building a third PP plant in South Korea. This facility will have a capacity of 200,000 t/y. The group currently produces around 380,000 t/y at two existing plants in Ulsan.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.